在社区药房中实施2a类药物审查:一项纵向调查研究
Eline Tobback1, Isabelle De Wulf2, Ella Wauters1
1Laboratory of Physiopharmacology, University of Antwerp (UA), Antwerp, Belgium.
Frontiers in pharmacology
|November 28, 2025
概括
比利时社区药房在实施药物审查类型2a (MR2a) 时面临诸如时间限制和合作不足等挑战. 培训和患者参与是促进者,但持续的支持对于成功的药物管理至关重要.
科学领域:
- 药房实践 在药房实践中
- 医疗保健服务研究 医疗服务研究
背景情况:
- 药物审查类型2a (MR2a) 于2023年4月在比利时社区药房引入,以改善药物使用和患者的治疗结果.
- 关于MR2a的实施状况和相关挑战在很大程度上仍未得到证实.
研究的目的:
- 记录比利时社区药房MR2a的实施情况.
- 确定促进和阻碍MR2a实施的因素.
主要方法:
- 进行了一项纵向调查研究.
- 从2023年10月到2024年10月,双语在线调查每季度分发给所有比利时社区药房.
- 这份由45项组成的调查问卷记录了药剂师对MR2a.的经验.
主要成果:
- 常见的障碍包括时间限制,符合隐私的沟通,人员短缺,咨询空间不足和与全科医生的合作不足.
- 确定的主要促进者是药剂师培训和患者参与.
- 持续的利益相关者支持被认为是成功实施MR2a的关键.
结论:
- 通过反复调查,可以及时了解MR2a的实施情况.
- 进展缓慢凸显了持续存在的障碍,需要持续支持和改善专业间合作.
- 预计调查结果将为国内和国际MR实施战略提供信息.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Drug Dosing: Geriatric Patients
212
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212
Dosage Regimens: Partial Pharmacokinetic Parameters
135
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
135
Analysis of Population Pharmacokinetic Data
657
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
657
Dosage Regimens: Designs and Approaches
242
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
242
Therapeutic Drug Monitoring: Drug Analysis Methods
164
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
164


